Stock Analysts

Ultragenyx’s Rare Disease Drug Mepsevii Gets EU Approval

Ultragenyx Pharmaceutical Inc. RARE announced that the European Commission (EC) has approved the Marketing Authorization Application (MAA) for Mepsevii (vestronidase alfa) for the treatment of non-neurological manifestations of Mucopolysaccharidosis VII (MPS VII), also known as Sly syndrome. We remind investors that Mepsevii, an enzyme replacement therapy, was approved in the United States in November 2017 for the treatment of children and adults with MPS VII […]

Stock Analysts

Eastman Chemical (EMN) Hikes Prices of Glycol Products

Eastman Chemical Company EMN is raising prices of Glycol Ethers and Glycol Ethers Esters, effective Sep 15, or as contracts permit. In North and Latin America, the company is lifting off-list prices of EB and DB Solvent as well as EB and DB Acetate by 3 cents per lb each. Eastman Chemical is taking appropriate pricing actions in response to rising raw material costs […]

Stock Analysts

Bayer’s Blood Thinner Xarelto Fails in Line Extension Studies

Bayer AG BAYRY and partner J&J JNJ announced data from two late-stage studies, which showed that its blood thinner drug, Xarelto failed to show statistical benefits. These studies were being evaluated to expand the drug’s eligible patient population. Data from the two phase III studies — MARINER and COMMANDER HF — showed no significant difference between Xarelto and placebo for the primary efficacy endpoints […]

Stock Analysts

New Buyouts Aid Boston Scientific Amid Dull Pacemaker Sales

On Aug 28, we issued an updated research report on Boston Scientific Corporation BSX . Boston Scientific’s recent acquisitions have added various new products (though many are under development) with immense potential to its portfolio. However, declining worldwide pacemaker sales in the recent past continued to weigh on the company's Cardiac Rhythm Management (CRM) results […]

Stock Analysts

Alphabet Roundup: Hardware, Privacy, App Store Tax, Health, China

Of the ton of Alphabet GOOGL news in the last few weeks, the following appear to be the most significant- Hardware News Alphabet has toyed with the idea of making hardware for quite a while now although it hasn’t really made a play for market share or made a big deal about share it picked up. But the fact remains that the company acquired Motorola Mobility only to swallow most of its patents and discard the rest of the company. Then earlier this year, it picked up HTC’s mobile business, again spurring rumors that it may be venturing into hardware, but we don’t really know. […]